Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.62468 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.72093 | 62 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.73418 | 62 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.63385 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.96523 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.76656 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.89504 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.72246 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.25027 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.69527 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.72245 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.35973 | 56 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.73961 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.73464 | 63 |